BOND.AI and Arkansas Heart Hospital Launch AI-Powered App to Analyze Health & Longevity

A file photo of Uday Akkaraju, CEO of BOND.AI and 101+

BOND.AI of Little Rock on Monday launched a new health care app in partnership with Arkansas Heart Hospital of Little Rock that aims to uncover the root causes of aging and chronic disease.

The 101+ app analyzes more than 150 clinical biomarkers and 500 data points through artificial intelligence. It also delivers personalized health recommendations based on an individual’s biological profile.

Uday Akkaraju, founder and CEO of both BOND.AI and 101+, said during a launch event at the Little Rock Regional Chamber that traditional “longevity tests,” which calculate life expectancy and wellness, can cost up to $250,000. The 101+ app has two subscription plans, and its test costs $999.

The app is launching in Arkansas first before expanding to the rest of the U.S. and other global markets. Those who wish to download and use the app must join a waitlist. After being accepted, users schedule a test at Arkansas Heart Hospital and fill out information in the app, then receive a body-aging analysis that covers cellular health, metabolic health, inflammation levels and stress indicators.

“AI can predict the rate at which your cells are aging, revealing whether you’re aging faster biologically than you are chronologically,” Akkaraju said. “We are now able to track specific biomarkers over time, connecting the dots between subtle changes in your blood work, cellular aging and other indicators of your health.”

It also identifies genetic predispositions to conditions like kidney disease, dementia or cancer, showing the risk of developing a disease as low, medium or high in the app. Based on those findings, 101+ provides tailored recommendations for supplements, therapies and other interventions designed to support healthy aging.

Akkaraju said at the event that a mobile test is already in place and being further developed for those who can’t physically go to the heart hospital.

After users take the necessary tests, the app identifies their “optimization zones,” or areas where health can be improved, and then the app’s AI creates a health “journey,” for users to follow.

The journey gives “insights and actions” to slow or reverse the aging process. And the journey can be adjusted day-to-day based on new data points the AI receives.

Arkansas Heart Hospital CEO Dr. Bruce Murphy helped found the app, giving Akkaraju an 18-month timeline to get the tech up and running.

“The insertion of appropriate AI into both finance and human health will be seen 100 or more years from now as just as vital as the invention of the printing press,” Murphy said at the event. “This is going to actually revolutionize how people take care of themselves. They don’t wait to get sick, they go back and fix it before it actually happens through a process that we have devised.”

Murphy and Akkaraju said the app is rooted in science and physician-informed AI. Many of the biomarkers and data points the app tests aren’t always checked by doctors, Murphy said, but 101+ needs a holistic view of a user’s cells.

“Ours is designed for health care. The impact of AI in your health in your future is dependent on how much you’re going to use it. And we’ve got the processes here to use it,” Murphy said. “Our basic goal here is to affect and focus on your molecular health, your cellular health.”

One challenge for the app will be trying to gain approval from the traditional medical community, Murphy explained at the event. He said it will happen, “but it’s not going to be at first.”